Jury Finds Pharma Exec 'Shadow Traded' With Inside Info <https://www.law360.com/compliance/articles/1822388?nl_pk=ab5ce197-c1fb-4d8e-a411-413bce38e654&utm_source=newsletter&utm_medium=email&utm_campaign=compliance&utm_content=2024-04-08&read_main=1&nlsidx=0&nlaidx=1> By Bonnie Eslinger A California federal jury found Friday that a former Medivation executive is liable for using inside information from his company when he purchased stock in rival pharmaceutical maker Incyte, in a novel civil "shadow trading" case brought by the U.S. Securities and Exchange Commission. Read full article » <https://www.law360.com/compliance/articles/1822388?nl_pk=ab5ce197-c1fb-4d8e-a411-413bce38e654&utm_source=newsletter&utm_medium=email&utm_campaign=compliance&utm_content=2024-04-08&read_more=1&nlsidx=0&nlaidx=1> | Save to favorites » <https://www.law360.com/compliance/articles/1822388?nl_pk=ab5ce197-c1fb-4d8e-a411-413bce38e654&utm_source=newsletter&utm_medium=email&utm_campaign=compliance&utm_content=2024-04-08&read_later=1&nlsidx=0&nlaidx=1>